Trial
NCT00477087
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
Bayer
Condition
Prostatic Neoplasms
Intervention
Mitoxantrone
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-29